Rahel KlatteUniversitätsklinikum Jena · Institut für Psychosoziale Medizin und Psychotherapie
Rahel Klatte
M.Sc. Psychology
About
5
Publications
1,302
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
41
Citations
Citations since 2017
Introduction
Rahel Klatte currently works at the Institut für Psychosoziale Medizin und Psychotherapie, Universitätsklinikum Jena. Rahel does research in Clinical Psychology. Their current project is 'Harmful effects of psychotherapy: systematic review and meta-analysis (HARMS).'
Education
October 2012 - November 2015
October 2009 - September 2012
Publications
Publications (5)
The assessment of safety data has become a standard across many clinical interventions. The aim of this systematic review is to investigate the extent to which harm is addressed within psychotherapy study protocols. The review includes study protocols of randomized controlled trials published between 2004 and 2017 investigating the effects of psych...
Background:
While it is well known that psychotherapy is efficacious in the treatment of mental disorders, much less is known about the adverse effects of psychotherapeutic interventions. The aim of this systematic review is to examine the definition, frequency, nature, and severity of adverse effects occurring parallel to or following psychothera...
Projects
Project (1)
(1) To assess the extent to which adverse events are specified in psychotherapy trial protocols and publications of psychotherapy trial results in general.
(2) To systematically examine the frequency, nature, and seriousness of adverse events occurring parallel or in the wake of psychotherapeutic treatment,
(3) To compare the heterogeneity, frequency, and longitudinal course of harmful effects of psychotherapeutic interventions against various control groups (untreated control groups, treatment as usual control groups, unspecific treatment control groups, pharmacotherapy or other psychotherapy interventions (head-to head comparisons)).
(4) To identify relevant moderators of the frequency of adverse events.
